Lucero, Marlo P.
HRN: 19-57-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
CEFTRIAXONE 1G (VIAL)
12/13/2024
12/20/2024
IV
2g
OD
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes